BX vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BX

51.2
AI Score
VS
IVZ Wins

IVZ

68.5
AI Score

Investment Advisor Scores

BX

Nov 11, 2026
51score
Recommendation
HOLD

IVZ

Nov 11, 2026
69score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BX IVZ Winner
Forward P/E 16.1551 8.4104 IVZ
PEG Ratio 1.1795 0.9008 IVZ
Revenue Growth -0.5% 14.2% IVZ
Earnings Growth 3.7% -1.5% BX
Tradestie Score 51.2/100 68.5/100 IVZ
Profit Margin 23.0% -1.1% BX
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD STRONG BUY IVZ

Relative Price Performance (Last 90 Days)

BX 1M: +6.8% · 3M: -16.3% IVZ 1M: -1.3% · 3M: -8.5%

Current Technical Phase

BX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.7 · Price: $122.53

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $28.87

Fundamentals Snapshot

Metric BX IVZ
Market Cap — —
Forward P/E 16.6 8.8
Trailing P/E 27.6 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.3%
Operating Margin 0.5% 0.2%
EPS 4.49 -0.69
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.